In line with these observations, drug resistant ovarian cancer cells show higher CD44 levels in vitro (44), while genetic overexpression of CD44s induces stem-like properties and chemoresistance in xenograft mouse models and ovarian cancer cell lines (44, 59). This evidence concerns the gene CD44 and ovarian cancer.